In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia

Blood

Volumn 90, Issue 7, 1997, Pages 2723-2729

  Kaspers, G J L ^a   Veerman, A J P ^b   Pieters, R ^b   Van Zantwijk, C H ^b   Smets, L A ^b   Van Wering, E R ^b   Van Der Does Van Den Berg, A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; COLORIMETRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT FAILURE;

EID: 0030815118     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.7.2723.2723_2723_2729     Document Type: Article

References (38)

1. Von Hoff DD: He's not going to talk about in vitro predictive assays again, is he? J Natl Cancer Inst 82:96, 1990
2. Gazdar A, Steinberg SM, Russell EC: Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive small cell lung cancer. A prospective clinical trial. J Natl Cancer Inst 82:117, 1990
3. Von Hoff DD, Sandbach JF, Clark GM, Turner JN, Forseth BF, Piccart MJ, Colombo N, Muggia FM: Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 82:110, 1990
4. Von Hoff DD, Kronmal R, Salmon SE, Turner J, Green JB, Bonorris JS, Moorhead EL, Hynes HE, Pugh RE, Belt RJ, Alberts D: A Southwest Oncology Group Study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer 67:20, 1991
5. Welander CE, Morgan TM, Homesly HD: Multiple factors predicting responders to combination chemotherapy in patients with ovarian cancer, in Salmon SE, Trent JM (eds): Human Tumor Cloning. Orlando, FL, Grune and Stratton, 1984, p 521
6. Wheeler TK, Dendy PP, Dawson A: Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology 3: 362, 1974
7. Hongo T, Fujii Y, Igarashi Y: An in vitro chemosensitivity test for the screening of anticancer drugs in childhood leukemia. Cancer 65:1263, 1990
8. Kaspers GJL, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, De Waal FC, Van Wering ER, Veerman AJP: Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: A preliminary analysis. Leukemia 8:1224, 1994
9. Larsson R, Kristensen J, Sandberg C, Nygren P: Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorimetric microculture cytotoxicity assay (FMCA). Int J Cancer 50:177, 1992
10. Pieters R, Kaspers GJL, Van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJP: Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Leukemia 7:392, 1993
11. Weisenthal LM, Dill PL, Finklestein JZ, Duarte TE, Baker JA, Moran EM: Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat Rep 70:1283, 1986
12. Klumper E, Pieters R, Kaspers GJL, Loonen AH, Huismans DR, Van Zantwijk CH, Hählen K, Van Wering ER, Henze G, Veerman AJP: In vitro cellular drug resistance in children with relapsed and refractory acute lymphoblastic leukemia. Blood 86:3681, 1995
13. Pieters R, Hongo T, Loonen AH, Huismans DR, Broxterman HJ, Hählen K, Veerman AJP: Non-p-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia. Br J Cancer 65:691, 1992
14. Asselin BL, Ryan D, Frantz CN, Bernai SD, Leavitt P, Sallan SE, Cohen HJ: In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res 49:4363, 1989
15. Dow LW, Dahl GV, Kalwinsky DK, Mirro J, Nash MB, Roberson PK: Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. Blood 68:400, 1986
16. Pieters R, Huismans DR, Loonen AH, Hählen K, Van Der Does-Van Den Berg A, Van Wering ER, Veerman AJP: Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 338:399, 1991
17. Smith PJ, Lihou MG: Prediction of remission induction in childhood acute myeloid leukemia. Aust NZ J Med 16:39, 1986
18. Bosanquet AG: Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay. Lancet 337:711, 1991
19. Delmer A, Marie J-P, Thevenin D, Cadiou M, Viguié F, Zittoun R: Multivariate analysis of prognostic factors in acute myeloid leukemia: Value of clonogenic leukemic cell properties. J Clin Oncol 7:738, 1989
20. Gustavsson A, Olofsson T: Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. Cancer Res 44:4648, 1984
21. Lathan B, Von Tettau M, Verpoort K, Diehl V: Pretherapeutic drug testing in acute leukemias for prediction of individual prognosis. Haematol Blood Transf 33:295, 1990
22. Park CH, Amare M, Savin MA, Goodwin JW, Newcomb MM, Hoostraten B: Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 55:595, 1980
23. Sargent JM, Taylor CG: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60:206, 1989
24. Tidefelt U, Sundman-Engberg B, Rhedin AS, Paul C: In vitro drug testing in patients mimicking in vivo intracellular drug concentrations. Eur J Haematol 43:374, 1989
25. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MWJ, Heyenbrok MW, Hählen K, Veerman AJP: In vitro sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76:2327, 1990
26. Veerman AJP, Pieters R: Drug sensitivity assays in leukaemia and lymphoma. Br J Haematol 74:381, 1990
27. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: The morphological classification of acute lymphoblastic leukaemia: Concordance among observers and clinical correlations. Br J Haematol 47:553, 1981
28. Van Wering ER, Brederoo P, Van Staalduinen GJ, Van Der Meulen J, Van Der Linden-Schrever BEM, Van Dongen JJM: Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children. Recent Results Cancer Res 131:77, 1993
29. Kaspers GJL, Pieters R, Van Zantwijk CH, De Waal FC, Van Wering ER, Veerman AJP: Is resistance to prednisolone in vitro related to the response to prednisolone at initial diagnosis in childhood acute lymphoblastic leukemia? A preliminary analysis, in Kaspers GJL, Pieters R, Twentyman PR, Weisenthal LM, Veerman AJP (eds): Drug Resistance in Leukemia and Lymphoma. The Clinical Value of Laboratory Assays. Chur, Switzerland, Harwood Academic, 1993, p 321
30. Smets LA, Homan-Blok, Hart A, De Vaan G, Behrendt H, Hählen K, De Waal FC: Prognostic implication of hyperdiploidy as based on DNA flow cytometric measurement in childhood acute lymphocytic leukemia - A multicenter study. Leukemia 1:163, 1987
31. Kaspers GJL, Pieters R, Van Zantwijk CH, De Laat PAJM, De Waal FC, Van Wering ER, Veerman AJP: In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Br J Cancer 64:469, 1991
32. Pieters R, Huismans DR, Leyva A, Veerman AJP: Adaptation of the rapid automated tetrazolium dye based MTT assay for chemosensitivity testing in childhood leukemia. Cancer Lett 41:323, 1988
33. Kaspers GJL, Veerman AJP, Pieters R, Broekema GH, Huismans DR, Kazimier KM, Loonen AH, Van Zantwijk CH, Hählen K, Van Wering ER: Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer 70:1047, 1994
34. Pieters R, Huismans DR, Leyva A, Veerman AJP: Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukemia. Br J Cancer 59:217, 1989
35. Riehm H, Feickert HJ, Schrappe M, Henze G, Schellong G: Therapy results in five ALL-BFM studies since 1970: Implications of risk factors for prognosis. Haematol Blood Transf 30:139, 1987
36. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
37. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972
38. Kaspers GJL, Smets LA, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJP: Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 85:751, 1995